Quantum Capacitance Based Amplified Graphene Phononics for Studying Neurodegenerative Diseases

Area of Science:

• Biophysics
• Neuroscience
• Materials Science

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset motor neuron disease with poorly understood pathobiology.
• Current diagnostic methods for ALS lack reliability and speed, hindering timely treatment initiation.
• There is a critical need for accurate and accessible diagnostic tools for neurodegenerative diseases.

Purpose of the Study:

• To investigate the potential of graphene's phonon vibration energies as a sensitive biomarker for ALS detection.
• To establish a method for analyzing cerebrospinal fluid (CSF) composition specific to ALS patients.
• To explore the specificity of this graphene-based method for differentiating between neurodegenerative diseases.

Main Methods:

• Utilized graphene's phonon vibration energies, specifically the 2D peak (second-order overtone), to measure the composite dipole moment of interfaced CSF.
• Analyzed the n-doping-induced shift in graphene's phonon energy when interfaced with CSF from ALS patients.
• Compared CSF signatures from ALS patients with those from patients with multiple sclerosis and other motor neuron diseases (MND).

Main Results:

• Observed a consistent shift of 3.2 ± 0.5 cm⁻¹ in graphene's 2D peak for all studied ALS patients.
• Demonstrated that the n-doping-induced shift in graphene's phonon energy is specific to the neurodegenerative disease investigated.
• Identified a unique compositional signature within the CSF of ALS patients detectable via graphene.

Conclusions:

• Graphene's phonon vibration energy serves as a sensitive and specific measure for detecting ALS through CSF analysis.
• This novel technology offers a potential solution to the diagnostic roadblock in ALS and other neurodegenerative diseases.
• The findings pave the way for developing diagnostic biomarkers and advancing therapeutic research for neurodegenerative conditions.